IL-1β Stimulated Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Rheumatoid Arthritis Via Inducing Apoptosis of Fibroblast-like Synoviocytes

Overview

Journal Sci Rep

Specialty Science

Date 2023 Sep 15

PMID 37714911

Authors

Yun-Hsuan Chiu

Ya-Han Liang

Jeng-Jong Hwang

Hwai-Shi Wang

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) is characterized by synovial proliferation and lymphocyte accumulation leading to progressive damage of the periarticular bone and the articular cartilage. The hyperplasia of the synovial intima lining mainly consists of fibroblast-like synoviocytes-rheumatoid arthritis (HFLS-RA) which exhibit apoptosis-resistance, hyper-proliferation, and high invasiveness. The therapeutic efficacy of mesenchymal stem cells (MSCs) treatment in RA has been shown to be due to its immuno-regulatory ability. However, the exact factors and mechanisms involved in MSCs treatment in RA remain unclear. In this study, TRAIL receptor-Death receptor 4 (DR4), DR5, and LFA-1 ligand-intercellular adhesion molecule-1 (ICAM-1) were upregulated in IL-1β-stimulated HFLS-RA. We demonstrated that the total cell number of IL-1β-stimulated hUCMSCs adhering to IL-1β-stimulated HFLA-RA increased via LFA-1/ICAM-1 interaction. Direct co-culture of IL-1β-stimulated hUCMSCs with IL-1β-stimulated HFLS-RA increased the apoptosis of HFLS-RA. RA symptoms in the CIA mouse model improved after administration of IL-1β-stimulated hUCMSCs. In conclusion, IL-1β-stimulated hUCMSCs adhering to HFLS-RA occurred via LFA-1/ICAM-1 interaction, apoptosis of HFLS-RA was induced via TRAIL/DR4, DR5 contact, and RA symptoms and inflammation were significantly improved in a CIA mouse model. The results of this study suggest that IL-1β-stimulated hUCMSCs have therapeutic potential in RA treatment.

Citing Articles

Emerging Landscape of Models for Assessing Rheumatoid Arthritis Management.

Mishra A, Kumar R, Harilal S, Nigam M, Datta D, Singh S ACS Pharmacol Transl Sci. 2024; 7(8):2280-2305.

PMID: 39144547 PMC: 11320735. DOI: 10.1021/acsptsci.4c00260.

The Role of Mesenchymal Stromal Cells in the Treatment of Rheumatoid Arthritis.

Bakinowska E, Bratborska A, Kielbowski K, Cmil M, Biniek W, Pawlik A Cells. 2024; 13(11.

PMID: 38891047 PMC: 11171813. DOI: 10.3390/cells13110915.

References

Guo Y, Chiu Y, Chen C, Wang H . Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res Ther. 2018; 9(1):281. PMC: 6202827. DOI: 10.1186/s13287-018-1032-9. View

Dayer J, de Rochemonteix B, Burrus B, Demczuk S, Dinarello C . Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986; 77(2):645-8. PMC: 423407. DOI: 10.1172/JCI112350. View

Audo R, Combe B, Coulet B, Morel J, Hahne M . The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases. Cell Death Differ. 2009; 16(9):1227-37. DOI: 10.1038/cdd.2009.38. View

Chinnadurai R, Ng S, Velu V, Galipeau J . Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease. World J Gastroenterol. 2015; 21(16):4779-87. PMC: 4408450. DOI: 10.3748/wjg.v21.i16.4779. View

Wong C, Chen D, Tam L, Li E, Yin Y, Lam C . Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2010; 12(4):R129. PMC: 2945019. DOI: 10.1186/ar3067. View

Schwarznau A, Hanson M, Sperger J, Schram B, Danobeitia J, Greenwood K . IL-1beta receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis. J Cell Physiol. 2009; 220(2):341-7. PMC: 2890273. DOI: 10.1002/jcp.21770. View

Kelley S, Harris L, Xie D, Deforge L, Totpal K, BUSSIERE J . Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther. 2001; 299(1):31-8. View

Zhang J, Zhou S, Zhou Y, Feng F, Wang Q, Zhu X . Adipose-Derived Mesenchymal Stem Cells (ADSCs) With the Potential to Ameliorate Platelet Recovery, Enhance Megakaryopoiesis, and Inhibit Apoptosis of Bone Marrow Cells in a Mouse Model of Radiation-Induced Thrombocytopenia. Cell Transplant. 2015; 25(2):261-73. DOI: 10.3727/096368915X688155. View

Liu S, Yuan M, Hou K, Zhang L, Zheng X, Zhao B . Immune characterization of mesenchymal stem cells in human umbilical cord Wharton's jelly and derived cartilage cells. Cell Immunol. 2012; 278(1-2):35-44. DOI: 10.1016/j.cellimm.2012.06.010. View

10.

Parekkadan B, Milwid J . Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010; 12:87-117. PMC: 3759519. DOI: 10.1146/annurev-bioeng-070909-105309. View

11.

Carrero R, Cerrada I, Lledo E, Dopazo J, Garcia-Garcia F, Rubio M . IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB. Stem Cell Rev Rep. 2012; 8(3):905-16. PMC: 3412085. DOI: 10.1007/s12015-012-9364-9. View

12.

Wu T, Liang Y, Wu J, Wang H . Interleukin-1 Enhances Umbilical Cord Mesenchymal Stem Cell Adhesion Ability on Human Umbilical Vein Endothelial Cells via LFA-1/ICAM-1 Interaction. Stem Cells Int. 2020; 2019:7267142. PMC: 6948307. DOI: 10.1155/2019/7267142. View

13.

Bartok B, Firestein G . Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010; 233(1):233-55. PMC: 2913689. DOI: 10.1111/j.0105-2896.2009.00859.x. View

14.

Truneh A, Sharma S, SILVERMAN C, Khandekar S, Reddy M, Deen K . Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor. J Biol Chem. 2000; 275(30):23319-25. DOI: 10.1074/jbc.M910438199. View

15.

Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S . Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018; 20(4):499-506. DOI: 10.1016/j.jcyt.2017.12.009. View

16.

Liang Y, Wu J, Teng J, Hung E, Wang H . Embelin downregulated cFLIP in breast cancer cell lines facilitate anti-tumor effect of IL-1β-stimulated human umbilical cord mesenchymal stem cells. Sci Rep. 2021; 11(1):14720. PMC: 8289868. DOI: 10.1038/s41598-021-94006-w. View

17.

Firestein G . Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996; 39(11):1781-90. DOI: 10.1002/art.1780391103. View

18.

Chen M, Lin C, Chiu Y, Chen C, Tsai P, Wang H . IL-1-Induced Matrix Metalloprotease-1 Promotes Mesenchymal Stem Cell Migration via PAR1 and G-Protein-Coupled Signaling Pathway. Stem Cells Int. 2018; 2018:3524759. PMC: 6031215. DOI: 10.1155/2018/3524759. View

19.

Igney F, Krammer P . Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002; 2(4):277-88. DOI: 10.1038/nrc776. View

20.

Wuttisarnwattana P, Eid S, Gargesha M, Cooke K, Wilson D . Cryo-imaging of Stem Cell Biodistribution in Mouse Model of Graft-Versus-Host-Disease. Ann Biomed Eng. 2020; 48(6):1702-1711. DOI: 10.1007/s10439-020-02487-z. View